Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-01-30
2007-01-30
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S310000, C514S839000, C514S912000, C514S944000, C536S123100, C536S124000, C536S128000, C424S401000, C424S402000, C424S427000, C424S659000, C507S209000, C507S241000, C507S271000, C166S300000, C166S308500
Reexamination Certificate
active
10997643
ABSTRACT:
The present invention is directed to ophthalmic compositions containing a gelling amount of a combination of galactomannan polysaccharides and borates. The compositions gel or partially gel upon administration to the eye. The present invention also discloses methods of topical ophthalmic administration of the compositions to the eye.
REFERENCES:
patent: 3843782 (1974-10-01), Krezanoski et al.
patent: 4136173 (1979-01-01), Pramoda et al.
patent: 4136177 (1979-01-01), Lin et al.
patent: 4136178 (1979-01-01), Lin et al.
patent: 4255415 (1981-03-01), Chrai et al.
patent: 4323467 (1982-04-01), Fu
patent: 4370325 (1983-01-01), Packman
patent: 4436730 (1984-03-01), Ellis et al.
patent: 4474751 (1984-10-01), Haslam et al.
patent: 4500441 (1985-02-01), Tanaka et al.
patent: 4861760 (1989-08-01), Mazuel et al.
patent: 5077033 (1991-12-01), Viegas et al.
patent: 5082579 (1992-01-01), Dawson
patent: 5126141 (1992-06-01), Henry
patent: 5145590 (1992-09-01), Dawson
patent: 5160643 (1992-11-01), Dawson
patent: 5188826 (1993-02-01), Chandrasekaran et al.
patent: 5192535 (1993-03-01), Davis et al.
patent: 5318780 (1994-06-01), Viegas et al.
patent: 5346703 (1994-09-01), Viegas et al.
patent: 5372732 (1994-12-01), Harris et al.
patent: 5376693 (1994-12-01), Viegas et al.
patent: 5457093 (1995-10-01), Cini et al.
patent: 5607698 (1997-03-01), Martin et al.
patent: 5653972 (1997-08-01), Desai et al.
patent: 5773025 (1998-06-01), Baichwal
patent: 5919742 (1999-07-01), Tsuzui et al.
patent: 5922340 (1999-07-01), Berde et al.
patent: 5972326 (1999-10-01), Galin et al.
patent: 6056950 (2000-05-01), Saettone et al.
patent: 6316506 (2001-11-01), Asgharian
patent: 6403609 (2002-06-01), Asgharian
patent: 6486138 (2002-11-01), Asgharian et al.
patent: 6495608 (2002-12-01), Asgharian
patent: 6583124 (2003-06-01), Asgharian
patent: 6838449 (2005-01-01), Asgharian
patent: 2005/0129771 (2005-06-01), Asgharian
patent: 0 386 960 (1990-09-01), None
patent: 6-345653 (1994-12-01), None
patent: 10221654 (1998-08-01), None
patent: WO 94/10976 (1994-05-01), None
patent: WO 97/30092 (1997-08-01), None
Ophthalmic Drug Facts '99,Facts and Comparisons, Ch. 3, St. Louis, MO, pp. 25-39 (1999).
Albasini, et al.; “Evaluation of Polysaccharides Intended for Ophthalmic Use in Ocular Dosage Forms”,II Farmaco,vol. 50 (9), pp. 633-642, (1995).
Power, et al., “Gel Transition Studies on Non-ideal Polymer Networks Using Small Amplitude Oscillatory Rheometry”,Journal of Rheology,vol. 42 (5), pp. 6-22, (1998).
The Merck Index;Twelfth Edition, 1996, p. 1548.
Bello, et al. “Effect of Intermolecular Cross Links on Drag Reduction by Polymer Solutions”,Polymer Bulletin,vol. 36, pp. 111-118 (1996).
Kesavan, et al., “Rheology of Guar and HPG Cross-Linked by Borate”,Macromolecules,vol. 25, pp. 2026-2032, (1992).
Alcon Manufacturing Ltd.
Brown Gregg C.
Jiang Shaojia Anna
Khare Devesh
LandOfFree
Ophthalmic compositions containing galactomannan polymers... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ophthalmic compositions containing galactomannan polymers..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic compositions containing galactomannan polymers... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3757815